Child and Adolescent OCD Outcomes From Exposure and Response Prevention Video Teletherapy Treatment

June 24, 2024 updated by: NOCD

Effectiveness of Video Teletherapy in Treating Child and Adolescent Obsessive-Compulsive Disorder With Exposure and Response Prevention: a Retrospective Longitudinal Observational Study

This is a naturalistic, observational study of children and adolescents with obsessive-compulsive disorder who were treated with exposure and response prevention via video teletherapy.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Study Type

Observational

Enrollment (Actual)

2173

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • United States
    • Illinois
      • Chicago, Illinois, United States, 60601
        • NOCD, Inc.

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child

Accepts Healthy Volunteers

No

Sampling Method

Non-Probability Sample

Study Population

This is a naturalistic sample of children and adolescents obsessive-compulsive disorder (OCD) who sought treatment for OCD from NOCD, Inc., a digital behavioral health company.

Description

Inclusion Criteria:

  • obsessive-compulsive disorder

Exclusion Criteria:

  • none

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Obsessive-Compulsive Disorder
adolescents and children with obsessive-compulsive disorder
Behavioral: Exposure and response prevention therapy
Exposures and response prevention therapy (a type of cognitive-behavioral therapy for obsessive-compulsive disorder), delivered in real-time by therapists remotely via video. The treatment was augmented by between-session text messaging.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Dimensional Obsessive-Compulsive Scale
Time Frame: change from pre-treatment to post-treatment (after 11 weeks)
self-rated psychometric instrument to measure symptom severity of multiple OCD subtypes (score range: 0-80)
change from pre-treatment to post-treatment (after 11 weeks)

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Depression Anxiety and Stress Scale (DASS-21)
Time Frame: pre-treatment, after 4 weeks, and post-treatment (after 11 weeks)
self-rated psychometric instrument to measure depression, anxiety, and stress (score range: 0-63)
pre-treatment, after 4 weeks, and post-treatment (after 11 weeks)

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

NOCD

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

July 23, 2020

Primary Completion (Actual)

May 3, 2024

Study Completion (Actual)

May 3, 2024

Study Registration Dates

First Submitted

June 14, 2024

First Submitted That Met QC Criteria

June 14, 2024

First Posted (Actual)

June 20, 2024

Study Record Updates

Last Update Posted (Actual)

June 26, 2024

Last Update Submitted That Met QC Criteria

June 24, 2024

Last Verified

June 1, 2024

More Information

Terms related to this study

Keywords

Additional Relevant MeSH Terms

Other Study ID Numbers

  • NOCD002

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Obsessive-Compulsive Disorder

Clinical Trials on Exposure and response prevention therapy

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Turkmenistan

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

Subscribe